Table 1 Demographic characteristics: intent-to-treat efficacy population
Prophylaxis group | Control group | Total | ||
|---|---|---|---|---|
n = 147 | n = 152 | N = 299 | ||
Gender | Female | 50.3% | 46.7% | 48.5% |
Male | 49.7% | 53.3% | 51.5% | |
Race | White | 98.6% | 98% | 98.3% |
Asian | 0.7% | 0.7% | 0.7% | |
Black / other | 0.7% / 0% | 0.7% / 0.7% | 0.7% / 0.3% | |
Body weight* in kg, median (min, max) | 5.9 (4.0, 7.6) | 5.9 (4.4, 8.2) | 5.9 (4.0, 8.2) | |
Age (months), median (min, max) | Dose 1 | 2.4 (1.9, 3.7) | 2.4 (1.9, 3.8) | 2.4 (1.9, 3.8) |
Dose 2 | 3.6 (2.8, 5.0) | 3.7 (2.7, 5.2) | 3.6 (2.7, 5.2) | |
Dose 3 | 4.7 (3.8, 6.4) | 4.8 (3.8, 6.3) | 4.7 (3.8, 6.4) | |
Toddler dose | 11.7 (10.2, 15.8) | 11.6 (11.0, 16.8) | 11.7 (10.2, 16.8) |